CIK 0001837607 · <br>Emerging growth company
AEON Biopharma, Inc.
Sign in to watch- Ticker
- AEON
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853940478
- Phone
- (949) 354-6499
- Business address
- 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
- Former names
- Priveterra Acquisition Corp.
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- UPLOAD Other SEC-generated Letter
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Auditor change
- UPLOAD Other SEC-generated Letter
- SC 13D/A Stake Beneficial Ownership Report
- DEL AM Other DEL AM
- S-1 Offering Registration Statement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 19 · 363 filings